«Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter’s new W1 wearable.»

«The collaboration allows vital sign data from the W1 watch to be sent to Philips’ patient monitoring ecosystem, so clinicians can keep an eye on patients after they’ve been discharged from the hospital.»

«Masimo launched the W1 for consumer use in August. At the time, the company said the watch tracks oxygen saturation, pulse rate, respiration rate and, in a limited release, hydration level. The device received a CE mark in Europe, but it is still awaiting FDA clearance.»

«Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care,» Bilal Muhsin, chief operating officer of Masimo Healthcare, said in a statement.»

Article written by Emily Olsen



Mobi Health News